Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain-Computer interface helps kids with cerebral palsy move their hands

NCT ID NCT07269353

Symptom relief Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a new therapy that combines a brain-computer interface (BCI) with electrical stimulation to help children with cerebral palsy move their arms and hands. Eight children aged 12 to 17 will wear a cap that reads their brain signals, and when they imagine moving their wrist, the system activates muscles to create the movement. The goal is to see if this approach is safe, tolerable, and improves hand function over 15 to 20 sessions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Brain-Computer Interface combined with Functional Electrical Stimulation (device)
What this could lead to
If it works, this could point toward a new, engaging therapy to help children with cerebral palsy regain hand and arm function, improving daily independence.
What could go wrong
This is a very small, early study with only 8 participants, so results may not apply to all children. The technology is still experimental and may not produce lasting improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 8 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Clinically confirmed and functionally disabling moderate to severe hemiparetic CP (GMFCS levels I-IV and MACS levels II\&III) with personalized goals that include improvement of wrist extension of affected upper extremity 2. Age 12-17 years, 3. Informed Consent/assent, 4. Normal corrected vision and hearing 5. Ability to maintain supported sitting for 30 min or more Exclusion Criteria: 1. Bilateral perinatal stroke 2. Motor strength of wrist extension zero 3. Severe hemiparesis (MACS V) 4. Severe developmental delay and/or other inability to comply with study protocol 5. Severe wrist contractures limiting wrist extension 6. Upper extremity orthopedic surgery or botulinum toxin in the preceding 6 months, 7. Initial classification accuracy below level of significance (as determined by the BCI system)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiparetic cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy cerebral palsy spastic hemiplegic spastic hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemiparetic cerebral palsy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Glenrose Rehabilitation Hospital

    RECRUITING

    Edmonton, Alberta, T5G 0B7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.